Lesch-nyhan Disease
📧 Sign up to get email alerts when something new happens for Lesch-nyhan Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-08-02Clinical Trial Update: Trial of Kuvan in Lesch-Nyhan Disease [Phase 2, Phase 3]
A clinical trial of Kuvan for behavioral manifestations in Lesch-Nyhan disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease [Phase 3]
Phase 3 trial of Ecopipam for self-injurious behavior in Lesch-Nyhan disease was terminated; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease [Phase 1]
Phase 1 results indicate safety and tolerability of Ecopipam, a D1 dopamine receptor antagonist, in patients with Lesch-Nyhan disease.